Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that subcutaneous testosterone pellets in peri- and postmenopausal women provided sustained hormone release and potential benefits for sexual function, but raised concerns about safety, variability, and dosing inconsistencies.

This review suggests that glucagon-like peptide 1 receptor agonists may play a potentially protective role in managing diabetic foot ulcers, particularly by addressing various underlying pathophysiological aspects.

This study reviews the use of lasers and light therapies as treatment options for managing the two most common types of alopecia—androegenetic alopecia and alopecia areata—highlighting that existing FDA-approved drugs like minoxidil and finasteride are partially effective, necessitating additional therapeutic approaches.

In this study, finasteride 1 mg daily did not improve hair loss in normoandrogenic postmenopausal women and had a similar adverse event profile to placebo within the first year.

This study highlights that topical melatonin formulations have the potential to increase hair density, prolong the hair growth phase, and reduce shedding in adults with alopecia, while generally being safe, though further large-scale randomized trials are needed to confirm its clinical efficacy.

This review suggests that Shirodhara, an ancient Ayurvedic therapy, may significantly improve mental well-being by reducing post-COVID anxiety, depression, and insomnia, although further randomized controlled trials are needed to confirm these promising findings.

This study highlights the multifaceted benefits of Phyllanthus emblica L. (amla), noting its potential impact on inflammation, oxidative stress, cardiovascular and gastrointestinal health, memory, skin aging, hair growth, and safety cautions with certain medications.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

This review discusses the potential benefits and safety concerns of using complementary and alternative medicine, such as traditional Chinese medicine herbs and probiotics, for treating pediatric atopic dermatitis, but reports no new clinical results.

In this review, spironolactone is highlighted for its emerging use in dermatology, particularly for treating androgen-mediated conditions like acne and hirsutism in susceptible females, though it requires careful monitoring for potential adverse effects.

This study found that Botox® was most effective at a 25 U/ml concentration, while Dysport® and Neurobloc® were optimal at 100 U/ml for producing anhidrotic areas after injections.

This study found that prenatal exposure to finasteride in rats disrupted male reproductive development, causing physical alterations such as delayed preputial separation and increased nipple retention.

This article provides issue information for the September 2020 edition of the British Journal of Dermatology and contains no new research findings.

This study found that systemic mycophenolate mofetil and topical clobetasol were equally effective at reducing lichen planopilaris activity over six months, but satisfaction differed between the treatments.

This randomized clinical trial found that vitamin D supplementation did not significantly alter anthropometric or metabolic parameters in obese, insulin-resistant, and vitamin D-deficient women with polycystic ovary syndrome, whereas metformin effectively reduced body weight, BMI, waist circumference, total body fat, and serum glucose levels.

In this study, behavioral disturbances were commonly observed with levetiracetam, while somnolence was frequently reported with oxcarbazepine among patients with refractory epilepsy.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

This study reports that discrepancies in adverse event reporting for clinical blood pressure trials undermine the reliability of safety data, suggesting a need for standardized reporting guidelines to improve trustworthiness.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Photobiomodulation is an effective and safe treatment for increasing hair growth in people with hair loss.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

This study found that prophylactic administration of autologous platelet-rich plasma during cesarean wound closure significantly improved wound quality and reduced the incidence of surgical site infections.

This review of studies published after 2020 found that probiotics may significantly reduce acne lesions and improve skin health in individuals with acne vulgaris, though further high-quality research is needed for confirmation and treatment optimization.

This systematic review found that platelet-rich plasma significantly improved hair density and count in androgenetic alopecia patients compared to controls, with minimal adverse effects reported.

This study reviewed various studies and concluded that Janus kinase inhibitors, particularly tofacitinib, seem to promote hair regrowth in about half of patients with alopecia areata, though expected class-specific adverse effects were observed.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

Finasteride helps hair growth in early male baldness, but more long-term research needed.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

This study emphasizes the importance of early diagnosis and a collaborative healthcare team in managing Sjogren’s Disease due to its complex nature and symptom variability, highlighting that timely treatment is crucial to prevent further damage.

This review discusses the role of androgens in the progression of cardiovascular disease and explores novel therapeutic targets without reporting new clinical results.